Results 91 to 100 of about 2,648 (201)

Quality of life of 26 family members from four generations with X-linked hypophosphatemia: a cross-sectional study

open access: yesFrontiers in Endocrinology
IntroductionX-linked hypophosphatemia (XLH) is a lifelong, progressive genetic condition affecting patients’ physical health and quality of life.MethodsThis cross-sectional study aimed to understand the burden of XLH on four generations of family members
Afaf I. Alsagheir   +11 more
doaj   +1 more source

Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project

open access: yes
Purpose: X-linked hypophosphatemia (XLH) is a rare multi-systemic disease characterized by low plasma phosphate levels. The aim of this study was to investigate the annual XLH prevalence and internally evaluate predictive algorithms' application ...
Lazzerini, Debora   +10 more
core   +1 more source

SUN-759 Real-World Outcomes in Late Adolescence Among Individuals With X-linked Hypophosphatemia (XLH): Results From the XLH Disease Monitoring Program

open access: yesJournal of the Endocrine Society
Abstract Disclosure: A.A. Khan: Ascendis, Takeda, Amolyt, Bridge Bio, Alexion Pharmaceuticals, Inc. E.A. Imel: Kyowa Kirin, Ultragenyx. L.M. Ward: Kyowa Kirin, Ultragenyx. T.O. Carpenter: Kyowa Kirin, Ultragenyx. J. Simmons: Kyowa Kirin, Ultragenyx. P.F. Florenzano: Kyowa Kirin, Ultragenyx. J. Li: Kyowa Kirin. S.
Khan, Aliya Aziz   +10 more
openaire   +1 more source

Lower limb maltorsion and acetabular deformity in children and adolescents with X-linked hypophosphatemia

open access: yesFrontiers in Endocrinology
BackgroundX-linked hypophosphatemia (XLH) is a rare monogenetic skeletal disorder. Lower limb deformities contribute substantially to impaired gait quality and burden of disease in patients with XLH.
Alexandra Stauffer   +10 more
doaj   +1 more source

Oral Health Status and Parental Awareness in Children with X-Linked Hypophosphatemic Rickets: A Case-Control Study

open access: yesReports
X-linked hypophosphatemic rickets (XLH) is a rare genetic disorder with a frequency of 1:20,000, caused by mutations in the PHEX gene, resulting in impaired phosphate metabolism and bone mineralization.
Victoria Zlateva   +3 more
doaj   +1 more source

Impact of stopping burosumab treatment at the end of skeletal growth in adolescents with X-linked hypophosphatemia (XLH)

open access: yes
Many adolescents with X-linked hypophosphatemia (XLH) currently have to stop treatment with burosumab at the end of skeletal growth. We describe the experience of a cohort of adolescents with XLH before, during, and after stopping burosumab (median ...
Angela Williams   +9 more
core   +1 more source

Disease burden and health-related quality of life among children with X-linked hypophosphataemia in China: a national cross-sectional survey

open access: yesBMJ Paediatrics Open
Background X-linked hypophosphataemia (XLH) is a rare inherited disorder often misdiagnosed and lacking sufficient aetiological treatment. Previous studies have shown that XLH is associated with worse health-related quality of life (HRQoL) and greater ...
Li Liu   +9 more
doaj   +1 more source

Overview of data collection schedule for quantitative and qualitative data relating to XLH symptoms and activity levels.

open access: yes
Overview of data collection schedule for quantitative and qualitative data relating to XLH symptoms and activity levels.
Pol Harvengt (17816963)   +11 more
core   +1 more source

9324 X-Linked Hypophosphatemic Rickets (XLH): Experience Argentina

open access: yesJournal of the Endocrine Society
Abstract Disclosure: E. Giacoia: Research Investigator; Self; Ultragenyx. A.C. Cantó: Research Investigator; Self; Ultragenyx. M.C. Balonga: Research Investigator; Self; Ultragenyx. Introduction: XLH is a genetic disease characterized by rickets and osteomalacia caused by pathogenic variants in PHEX with disruptions in ...
Giacoia, E, Cantó, A C, Balonga, M C
openaire   +1 more source

X-linked Hypophosphatemia (XLH): Burosumab Significantly Improved Rickets and Standing Height Z-Score Compared with Conventional Therapy in Children with XLH [PDF]

open access: yesJournal of Pediatric Nursing, 2020
Marian Hart   +7 more
openaire   +1 more source

Home - About - Disclaimer - Privacy